Ben Sykes, BSc BVMS MSc MBA DACVIM PhD FHEA: No relevant disclosure to display
Presentation Description / Summary: Refractory gastric disease is common in the horse, especially glandular gastric disease. The purpose of this lecture is to discuss a range of strategies used by the presenter to manage refractory gastric disease with a specific shift away from long-term pharmaceutical management towards targeted symptomatic management and behaviorally focused strategies. Strategies discussed include enhancing the timing of feeding and exercise, the evidence-based use of nutraceuticals, and the targeted use of appropriate pharmaceuticals. Managing learnt behavior and focusing on the clinical presentation as a pain-based disease is also discussed.
Learner Outcomes: - Discuss the potential factors contributing to refractory gastric disease in the horse. - Discuss a range of strategies, including behavioral, to manage refractory gastric disease in the horse.
Learning Objectives:
Describe the therapeutic response of EGGD to currently available pharmaceutical treatments.
Discuss the evdience-based use of nutraceutical supplements in the management of refractory EGGD.
Discuss the use of adjunctive strategies in the management of refractory EGGD.
